Stockscreener 앱 받기
19.13
2.15%
-0.42
전일 마감가:
$19.55
열려 있는:
$19.3
하루 거래량:
184.97K
Relative Volume:
3.01
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.07%
1개월 성능:
+24.87%
6개월 성능:
-35.24%
1년 성능:
-31.41%
1일 변동 폭
$19.12
$19.54
1주일 범위
$18.28
$19.94
52주 변동 폭
$13.42
$31.65
Virtus Lifesci Biotech Clinical Trials Etf Stock (BBC) Company Profile
명칭
Virtus Lifesci Biotech Clinical Trials Etf
전화
-
주소
-
BBC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBC
Virtus Lifesci Biotech Clinical Trials Etf
|
19.15 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
278.17 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
565.25 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
567.85 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
221.73 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
487.67 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Clinical Trials Etf 주식(BBC)의 최신 뉴스
ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On - Benzinga
Tech Rally Boosted Wall Street Last Week: Winning ETFs in Focus - TradingView
6 Best-Performing ETFs of Last Week - TradingView
(BBC) Investment Analysis and Advice - news.stocktradersdaily.com
Wall Street Week Ahead - Seeking Alpha
(BBC) Technical Data - news.stocktradersdaily.com
Trend Tracker for (BBC) - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBC) Trading Signals - Stock Traders Daily
(BBC) Trading Advice - Stock Traders Daily
(BBC) Proactive Strategies - Stock Traders Daily
Learn to Evaluate (BBC) using the Charts - Stock Traders Daily
Stock Market Movers Today • Top Gainers & Losers - Benzinga
When (BBC) Moves Investors should Listen - Stock Traders Daily
(BBC) Long Term Investment Analysis - Stock Traders Daily
How to Take Advantage of moves in (BBC) - Stock Traders Daily
(BBC) Pivots Trading Plans and Risk Controls - Stock Traders Daily
Capitulation in biotech is near, as well as a rally – Piper Sandler (NYSEARCA:XBI) - Seeking Alpha
The Great Rotation: Just Getting Started? - ETF Trends
5 Top ETFs of Last Week - Nasdaq
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - TipRanks
Pharma Stocks Look Cheap. Here's One Way To Invest. - Barchart
9 Best Biotech ETFs for 2024 - MSN
The 5 Best Biotech ETFs of 2024 - ETF.com
5 Best ETF Areas of Last Week - Nasdaq
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Top and Flop Industry ETFs of Q3 - Nasdaq
ETFs to Play Biden's 2024 Reelection Campaign Launch - Nasdaq
ALPS’ Biotech ETF SBIO Week’s Top Performer - Nasdaq
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - Financial Advisor (Mag)
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Biotech ETFs Are Making a Comeback - ETF Trends
Best Performing ETFs For June 2022 - TheStreet
Biotech ETF Tops in June: 5 Stocks That Outperform - Yahoo Finance
Betting on Biotech Bear Market Expiration Date - ETF Trends
Best & Worst Performing ETFs Of 2022 - Yahoo Finance
Positioning for Biotech Bounceback - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
ETF Exchange: Latest ETF News & Insights | Pensions & Investments - Pensions & Investments
Biotech Ready to Participate in Healthcare Bullishness - Nasdaq
Drug Price Debate Might Not Hinder Biotech ETFs - ETFdb.com
Size Up SBIO Ahead of Biotech Rebound - ETF Trends
Finding Synergy With SPY - etf.com
Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News - Zacks Investment Research
Biotech ETFs Surge on Biogen's Alzheimer Drug Approval - Yahoo Finance
After AstraZeneca, Oxford Nanopore Might Be The Next UK COVID Winner - Investing.com
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
Unless Sorrento Makes Solid Progress Soon, It Will Likely Go Below $5 - Nasdaq
A Healthcare ETF Review: Biotech Beckons under Biden - ETF Trends
Medical Breakthrough ETFs for More than Just COVID - ETF Database
Virtus Lifesci Biotech Clinical Trials Etf (BBC) 재무 분석
Virtus Lifesci Biotech Clinical Trials Etf (BBC)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.37%
0.08%
자본화:
|
볼륨(24시간):